Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbdependent expression of the Wnt antagonist, sclerostin.

Detalles Bibliográficos
Publicado en:Breast Cancer Research Vol. 13; no. 4; pp. 3048 - 3062
Formato: Journal Article
Publicado: BioMed Central 2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=70241673&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 70241673
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14655411
        8UYJ
      jtl: Breast Cancer Research
      issn: 14655411
      maglogo: N
    pubinfo:
      dt: 2011
      vid: 13
      iid: 4
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        70241673
        10.1186/bcr3048
        70241673
      ppf: 3048
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbdependent expression of the Wnt antagonist, sclerostin.
      aug:
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N